联合治疗长期抑制后血浆HIV病毒载量的反弹。 - Suppr

Suppr

超能文献

Rebound of plasma HIV viral load following prolonged suppression with combination therapy.

作者信息

Montaner J S, Harris M, Mo T, Harrigan P R

出版信息

AIDS. 1998 Jul 30;12(11):1398-9. doi: 10.1097/00002030-199811000-00028.

DOI:10.1097/00002030-199811000-00028

PMID:9708426

Abstract

摘要

相似文献

Rebound of plasma HIV viral load following prolonged suppression with combination therapy.联合治疗长期抑制后血浆HIV病毒载量的反弹。

AIDS. 1998 Jul 30;12(11):1398-9. doi: 10.1097/00002030-199811000-00028.

Researchers report sustained suppression of HIV with nevirapine--didanosine--zidovudine.研究人员报告称，使用奈韦拉平-去羟肌苷-齐多夫定可实现对艾滋病毒的持续抑制。

Am J Health Syst Pharm. 1998 Jun 1;55(11):1106, 1108. doi: 10.1093/ajhp/55.11.1106.

Viral load--how low is best?

TreatmentUpdate. 1998 Dec;10(10):2-3.

Maintaining a low viral load with Nevirapine?使用奈韦拉平维持低病毒载量？

TreatmentUpdate. 1998 Dec;10(10):3-4.

Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection.

AIDS. 2001 Jan 26;15(2):275-7. doi: 10.1097/00002030-200101260-00020.

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.一项比较奈韦拉平、去羟肌苷和齐多夫定联合用药对HIV感染患者疗效的随机双盲试验：INCAS试验。意大利、荷兰、加拿大和澳大利亚研究。

JAMA. 1998 Mar 25;279(12):930-7. doi: 10.1001/jama.279.12.930.

Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.

AIDS. 1998 Jun 18;12(9):1113-4.

Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.奈韦拉平、去羟肌苷和齐多夫定用于HIV患者：INCAS试验。意大利、荷兰、加拿大和澳大利亚。

JAMA. 1999 Jan 13;281(2):130-1.

Patients with HIV-1 RNA below 1000 copies/ml after 48 weeks on dual nucleoside combination therapy. Delta Coordinating Committee.

AIDS. 1999 Feb 25;13(3):430-1. doi: 10.1097/00002030-199902250-00023.

Induction-maintenance antiretroviral therapy: proof of concept.

AIDS. 1998 May 7;12(7):F41-4. doi: 10.1097/00002030-199807000-00001.

引用本文的文献

Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size.维得利珠单抗联合抗逆转录病毒疗法治疗新近感染 HIV-1 可揭示 α4β7 在储存库大小中的作用。

JCI Insight. 2024 Jul 9;9(16):e182312. doi: 10.1172/jci.insight.182312.

HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.HIV在肠道相关淋巴组织中的持续存在：药理学挑战与机遇

AIDS Res Hum Retroviruses. 2017 Jun;33(6):513-523. doi: 10.1089/AID.2016.0253. Epub 2017 May 16.

A Mediation Model to Explain HIV Antiretroviral Adherence Among Gay and Bisexual Men.一个用于解释男同性恋者和双性恋男性中艾滋病毒抗逆转录病毒治疗依从性的中介模型。

J Gay Lesbian Soc Serv. 2008;19(1):35-55. doi: 10.1300/J041v19n01_03.

Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.B方案高效抗逆转录病毒疗法（HAART）预防HIV感染孕妇母婴传播（PMTCT）的有效性。

BMC Res Notes. 2014 Jan 21;7:52. doi: 10.1186/1756-0500-7-52.

Modeling antiretroviral drug responses for HIV-1 infected patients using differential equation models.利用微分方程模型对感染 HIV-1 的患者的抗逆转录病毒药物反应进行建模。

Adv Drug Deliv Rev. 2013 Jun 30;65(7):940-53. doi: 10.1016/j.addr.2013.04.005. Epub 2013 Apr 17.

HIV infection: what should be considered in approaches for a cure?HIV感染：治愈方案应考虑哪些因素？

AIDS. 2012 Nov 13;26(17):2253-5. doi: 10.1097/QAD.0b013e32835ac83a.

Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings.开发一种易于使用的工具，用于评估青少年临床护理环境中的艾滋病毒治疗准备情况。

AIDS Care. 2011 Nov;23(11):1492-9. doi: 10.1080/09540121.2011.565020. Epub 2011 Jun 21.

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.用于检测血浆中1型人类免疫缺陷病毒RNA的具有单拷贝敏感性的新型实时逆转录起始PCR检测法。

J Clin Microbiol. 2003 Oct;41(10):4531-6. doi: 10.1128/JCM.41.10.4531-4536.2003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验